Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

Le résumé fourni par la source

Address: 1Mailman School of Public Health, Columbia University, New York. New York, USA, 2Columbia University – South Africa Fogarty AIDS International Training and Research Program, New York, New York, USA, 3PI NCT00380770, 4Department of Dermatology, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa, 5Department of Oncology, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa, 6Victor Daitz Chair of HIV Research, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa, 7Yale University, New Have, Connecticut, USA and 8Harvard Medical School, Boston, Massachusetts, USA * Corresponding author

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.